Beneficial and ominous aspects of the pleiotropic action of erythropoietin.
about
Erythropoietin or darbepoetin for patients with cancerErythropoietin or Darbepoetin for patients with cancerHypoxic regulation of erythropoiesis and iron metabolismMolecular mechanisms of ischemic preconditioning in the kidneyDifferential modulation of angiogenesis by erythropoiesis-stimulating agents in a mouse model of ischaemic retinopathyUse of high-dose erythropoietin for repair after injury: A comparison of outcomes in heart and kidney.Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients.Erythropoietin-induced proliferation of gastric mucosal cellsA program for ligation at threonine sites: application to the controlled total synthesis of glycopeptides.Erythropoietin and cancer: the unintended consequences of anemia correctionErythropoietin promotes survival of primary human endothelial cells through PI3K-dependent, NF-kappaB-independent upregulation of Bcl-xL.Erythropoietin after a century of research: younger than ever.Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis.Attenuation of inflammation and apoptosis by pre- and posttreatment of darbepoetin-alpha in acute liver failure of miceNeurological diseases as primary gliopathies: a reassessment of neurocentrismAnalysis of the erythropoietin of a Tibetan Plateau schizothoracine fish (Gymnocypris dobula) reveals enhanced cytoprotection function in hypoxic environmentsNew avenues of exploration for erythropoietin.Role of erythropoietin in the brainContrasting effect of recombinant human erythropoietin on breast cancer cell response to cisplatin induced cytotoxicityGlutaraldehyde erythropoietin protects kidney in ischaemia/reperfusion injury without increasing red blood cell production.Recombinant human erythropoietin alpha modulates the effects of radiotherapy on colorectal cancer microvessels.Hypoxia alters progression of the erythroid program.Targeted erythropoietin selectively stimulates red blood cell expansion in vivo.Multiple doses of erythropoietin impair liver regeneration by increasing TNF-alpha, the Bax to Bcl-xL ratio and apoptotic cell deathEpoetin beta once weekly: review of its efficacy and safety in patients with chemotherapy-induced anemia.The role of erythropoietin as an inhibitor of tissue ischemia.Multiorgan-protective actions of blockers of the renin-angiotensin system, statins and erythropoietin: common pleiotropic effects in reno-, cardio- and neuroprotection.Migration of bone marrow-derived cells and improved perfusion after treatment with erythropoietin in a murine model of myocardial infarctionToward fully synthetic homogeneous beta-human follicle-stimulating hormone (beta-hFSH) with a biantennary N-linked dodecasaccharide. synthesis of beta-hFSH with chitobiose units at the natural linkage sites.Targeting astrocytes for stroke therapy.Hematopoietic cytokines for cardiac repair: mobilization of bone marrow cells and beyond.The nonhematopoietic effects of erythropoietin in skin regeneration and repair: from basic research to clinical use.Cytokines: shifting the balance between glioma cells and tumor microenvironment after irradiation.Erythropoietin is involved in hemoprotein syntheses in developing human decidua.Glia-neuron interactions in neurological diseases: Testing non-cell autonomy in a dish.Angiogenic growth factors in myocardial infarction: a critical appraisal.Protective effects of erythropoietin against acute lung injury in a rat model of acute necrotizing pancreatitis.Intracardiac injection of erythropoietin induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model.The anemia of the newborn induces erythropoietin expression in the developing mouse retina.Erythropoietin in sepsis: a new use for a familiar drug?
P2860
Q24202335-9BBB84A9-872D-4BEC-AA56-9933A0D2891CQ24245464-CAD54263-EEF7-4A22-A557-07AC7C811606Q24609166-05841A6A-B7AD-4F0D-9A21-AC3A46545F95Q28080772-7606B0F8-790E-4D11-936A-A59EA9635406Q28750073-D0B52109-BC6F-4852-9378-FADBA9F9BDE5Q30486662-BD03FB08-A3F1-4CC0-A0A6-8EF2D82CA721Q33243661-BAF036AF-C929-4B72-A07B-7DB8E4BBB7CBQ33788117-B52ACA2F-9FED-4EA2-B97A-4D5B33E37E2FQ34078234-358BF72F-0098-41EE-9422-7B593D692082Q34488415-C7563E1F-2019-4FA5-B47A-68B563DFF8C1Q34604185-775C9D67-F9D0-404A-8AC1-A749D4D36D23Q34606348-25DDEA52-2ECC-4793-BD0E-EB1664D483ADQ35800467-5A3C2255-7911-410B-B8F2-1F90B5C34F16Q35855561-E0C4E58F-3EFF-4B78-82D8-86F70CD48D70Q35872654-26CA2617-B570-4562-8DE4-C65D1F41AEF1Q35894470-8457237D-A2B8-48DF-B570-F52F6AA95C87Q35999785-A7C2F849-AC08-4D66-A520-DCF223DB8464Q36153802-52571612-DCB5-42D4-B0C6-C9C5BC5F0735Q36322416-98155FAC-6A79-437E-8BDA-0DDB538DAE94Q36603218-C9ADC0CD-0FE9-4D4D-A25B-29BDCF847212Q36610013-3495DE62-6AA0-4083-96A6-AEBF0AFA5FC5Q36714156-B1BEC15F-50D7-451E-A95E-D909467A4A4EQ36905103-F7305F55-C6A6-412D-AF69-27A4EEC8781BQ36993016-5FBB0E4C-F93A-495A-AB21-F3EEB0545E65Q37183442-354CDC31-EA78-4B6E-8272-DB4C54A608B5Q37195742-BF1951BC-D5AC-487C-B1AC-FA668D07B18CQ37247753-51FFE245-9D19-435D-A0E9-68254BE48472Q37295247-81089116-86B6-4191-8E47-A771E67B429FQ37373965-044C5941-65FE-4E3C-8482-8B829504DDFEQ37794392-C9EFDD78-0E57-4E10-9EAA-CEC0B9C0E871Q37871920-991763F9-6BA4-4330-906C-9F370388F507Q37995093-CE934F40-DFA6-4277-B4C2-BB39D8E7ACC4Q38227496-D9D01D86-AFC9-4E8D-ACB9-C5C8C4B587A3Q38317165-5B6C8152-32FF-4EA2-9244-2A9D403EA16CQ38700229-1369D53C-9F95-4E36-B069-BF1C50CC7F6FQ39389842-999DEBEE-96FA-41D0-86D4-59C8037B8539Q42043393-C18CB7C2-0D0B-481A-BA36-E6666E82858BQ42154280-A8BF5213-35F3-4480-8C71-2F44925BB2D1Q42170481-8322BEFF-7B4E-4E16-A78E-B893FFD129A5Q43137414-9D34B1E4-E583-43B5-8177-1BA274019AEF
P2860
Beneficial and ominous aspects of the pleiotropic action of erythropoietin.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Beneficial and ominous aspects of the pleiotropic action of erythropoietin.
@ast
Beneficial and ominous aspects of the pleiotropic action of erythropoietin.
@en
type
label
Beneficial and ominous aspects of the pleiotropic action of erythropoietin.
@ast
Beneficial and ominous aspects of the pleiotropic action of erythropoietin.
@en
prefLabel
Beneficial and ominous aspects of the pleiotropic action of erythropoietin.
@ast
Beneficial and ominous aspects of the pleiotropic action of erythropoietin.
@en
P1433
P1476
Beneficial and ominous aspects of the pleiotropic action of erythropoietin.
@en
P2093
Klaus Wagner
Wolfgang Jelkmann
P304
P356
10.1007/S00277-004-0911-6
P577
2004-08-21T00:00:00Z